Robin L. Smith, Director at Sorrento Therapeutics, Inc. (SRNE), bought 40,000 shares at $2.27 ($91K) on 2020-03-05, disclosed to the SEC on 2020-03-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| NBS | BUY | 2012-09-18 | $25K | — | Filing → |
| NBS | BUY | 2011-12-15 | $30K | — | Filing → |
| NBS | BUY | 2011-03-02 | $8K | — | Filing → |